Exploring the Ability of Electronic Nose Technology to Recognize Interstitial 
Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile 
Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and 
Biobank

Krauss, Ekaterina; Haberer, Jana; Maurer, Olga; Barreto, Guillermo; Drakopanagiotakis, Fotios; Degen, Maria; Seeger, Werner; Guenther, Andreas

doi:10.3390/jcm8101698

Lokale TagsFreigabegeschichteDetailsÜbersicht

Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank

Krauss, E., Haberer, J., Maurer, O., Barreto, G., Drakopanagiotakis, F., Degen, M., et al. (2019). Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank. JOURNAL OF CLINICAL MEDICINE, 8(10): 1698. doi:10.3390/jcm8101698.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-0006-AEB1-E Versions-Permalink: https://hdl.handle.net/21.11116/0000-0006-AEB2-D

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Krauss, Ekaterina, Autor
Haberer, Jana, Autor
Maurer, Olga, Autor
Barreto, Guillermo¹, Autor
Drakopanagiotakis, Fotios, Autor
Degen, Maria, Autor
Seeger, Werner², Autor
Guenther, Andreas, Autor

Affiliations:
1Lung Cancer Epigenetics, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591699
2Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591698